119 related articles for article (PubMed ID: 38030063)
61. Reclassification of risk of malignancy with Percepta Genomic Sequencing Classifier following nondiagnostic bronchoscopy.
Raval AA; Benn BS; Benzaquen S; Maouelainin N; Johnson M; Huang J; Lofaro LR; Ansari A; Geurink C; Kennedy GC; Bulman WA; Kurman JS
Respir Med; 2022; 204():106990. PubMed ID: 36283245
[TBL] [Abstract][Full Text] [Related]
62. A Noninvasive Multianalytical Approach for Lung Cancer Diagnosis of Patients with Pulmonary Nodules.
Liu QX; Zhou D; Han TC; Lu X; Hou B; Li MY; Yang GX; Li QY; Pei ZH; Hong YY; Zhang YX; Chen WZ; Zheng H; He J; Dai JG
Adv Sci (Weinh); 2021 Jul; 8(13):2100104. PubMed ID: 34258160
[TBL] [Abstract][Full Text] [Related]
63. A model based on the quantification of complement C4c, CYFRA 21-1 and CRP exhibits high specificity for the early diagnosis of lung cancer.
Ajona D; Remirez A; Sainz C; Bertolo C; Gonzalez A; Varo N; Lozano MD; Zulueta JJ; Mesa-Guzman M; C Martin A; Perez-Palacios R; Perez-Gracia JL; Massion PP; Montuenga LM; Pio R
Transl Res; 2021 Jul; 233():77-91. PubMed ID: 33618009
[TBL] [Abstract][Full Text] [Related]
64. Development and Validation of Machine Learning-based Model for the Prediction of Malignancy in Multiple Pulmonary Nodules: Analysis from Multicentric Cohorts.
Chen K; Nie Y; Park S; Zhang K; Zhang Y; Liu Y; Hui B; Zhou L; Wang X; Qi Q; Li H; Kang G; Huang Y; Chen Y; Liu J; Cui J; Li M; Park IK; Kang CH; Shen H; Yang Y; Guan T; Zhang Y; Yang F; Kim YT; Wang J
Clin Cancer Res; 2021 Apr; 27(8):2255-2265. PubMed ID: 33627492
[TBL] [Abstract][Full Text] [Related]
65. External validation and recalibration of the Brock model to predict probability of cancer in pulmonary nodules using NLST data.
Winter A; Aberle DR; Hsu W
Thorax; 2019 Jun; 74(6):551-563. PubMed ID: 30898897
[TBL] [Abstract][Full Text] [Related]
66. A blood-based proteomic classifier for the molecular characterization of pulmonary nodules.
Li XJ; Hayward C; Fong PY; Dominguez M; Hunsucker SW; Lee LW; McLean M; Law S; Butler H; Schirm M; Gingras O; Lamontagne J; Allard R; Chelsky D; Price ND; Lam S; Massion PP; Pass H; Rom WN; Vachani A; Fang KC; Hood L; Kearney P
Sci Transl Med; 2013 Oct; 5(207):207ra142. PubMed ID: 24132637
[TBL] [Abstract][Full Text] [Related]
67. Comparing modalities for risk assessment in patients with pulmonary lesions and nondiagnostic bronchoscopy for suspected lung cancer.
Yu DH; Shafiq M; Batra H; Johnson M; Griscom B; Chamberlin J; Lofaro LR; Huang J; Bulman WA; Kennedy GC; Yarmus LB; Lee HJ; Feller-Kopman D
BMC Pulm Med; 2022 Nov; 22(1):442. PubMed ID: 36434574
[TBL] [Abstract][Full Text] [Related]
68. Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study.
Walter JE; Heuvelmans MA; Bock GH; Yousaf-Khan U; Groen HJM; Aalst CMV; Nackaerts K; Ooijen PMAV; Koning HJ; Vliegenthart R; Oudkerk M
Thorax; 2018 Aug; 73(8):741-747. PubMed ID: 29661918
[TBL] [Abstract][Full Text] [Related]
69. Evaluating the diagnostic accuracy of a ctDNA methylation classifier for incidental lung nodules: protocol for a prospective, observational, and multicenter clinical trial of 10,560 cases.
Liang W; Liu D; Li M; Wang W; Qin Z; Zhang J; Zhang Y; Hu Y; Bao H; Xiang Y; Wang B; Wu J; Sun J; Hu C; Ye X; Zhang X; Xiao W; Yun C; Sun D; Wang W; Chang N; Zhang Y; Zhao J; Zhang X; Xu J; Wu D; Liu X; Guo Y; Zhang Q; Zhang W; Yang L; Li Z; Zhang X; Han B; Tong Z; He J; Qu J; Fan JB; Zhong N
Transl Lung Cancer Res; 2020 Oct; 9(5):2016-2026. PubMed ID: 33209621
[TBL] [Abstract][Full Text] [Related]
70. Radiomics analysis to predict pulmonary nodule malignancy using machine learning approaches.
Warkentin MT; Al-Sawaihey H; Lam S; Liu G; Diergaarde B; Yuan JM; Wilson DO; Atkar-Khattra S; Grant B; Brhane Y; Khodayari-Moez E; Murison KR; Tammemagi MC; Campbell KR; Hung RJ
Thorax; 2024 Mar; 79(4):307-315. PubMed ID: 38195644
[TBL] [Abstract][Full Text] [Related]
71. Models to Estimate the Probability of Malignancy in Patients with Pulmonary Nodules.
Choi HK; Ghobrial M; Mazzone PJ
Ann Am Thorac Soc; 2018 Oct; 15(10):1117-1126. PubMed ID: 30272500
[TBL] [Abstract][Full Text] [Related]
72. Diagnosis of Benign and Malignant Pulmonary Ground-Glass Nodules Using Computed Tomography Radiomics Parameters.
Liang L; Zhang H; Lei H; Zhou H; Wu Y; Shen J
Technol Cancer Res Treat; 2022; 21():15330338221119748. PubMed ID: 36259167
[No Abstract] [Full Text] [Related]
73. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
74. Tumor-derived Autoantibodies Identify Malignant Pulmonary Nodules.
Lastwika KJ; Kargl J; Zhang Y; Zhu X; Lo E; Shelley D; Ladd JJ; Wu W; Kinahan P; Pipavath SNJ; Randolph TW; Shipley M; Lampe PD; Houghton AM
Am J Respir Crit Care Med; 2019 May; 199(10):1257-1266. PubMed ID: 30422669
[No Abstract] [Full Text] [Related]
75. A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.
Silvestri GA; Vachani A; Whitney D; Elashoff M; Porta Smith K; Ferguson JS; Parsons E; Mitra N; Brody J; Lenburg ME; Spira A;
N Engl J Med; 2015 Jul; 373(3):243-51. PubMed ID: 25981554
[TBL] [Abstract][Full Text] [Related]
76. Combination of positron emission tomography/computed tomography and chest thin-layer high-resolution computed tomography for evaluation of pulmonary nodules: Correlation with imaging features, maximum standardized uptake value, and pathology.
Hou S; Lin X; Wang S; Shen Y; Meng Z; Jia Q; Tan J
Medicine (Baltimore); 2018 Aug; 97(31):e11640. PubMed ID: 30075545
[TBL] [Abstract][Full Text] [Related]
77. [Establishment and Verification of A Novel Predictive Model of Malignancy
for Non-solid Pulmonary Nodules].
Xiao F; Yu Q; Zhang Z; Liu D; Liang C
Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):26-33. PubMed ID: 30674390
[TBL] [Abstract][Full Text] [Related]
78. Computer-aided diagnosis of pulmonary nodules using a two-step approach for feature selection and classifier ensemble construction.
Lee MC; Boroczky L; Sungur-Stasik K; Cann AD; Borczuk AC; Kawut SM; Powell CA
Artif Intell Med; 2010 Sep; 50(1):43-53. PubMed ID: 20570118
[TBL] [Abstract][Full Text] [Related]
79. A Low-Dose CT-Based Radiomic Model to Improve Characterization and Screening Recall Intervals of Indeterminate Prevalent Pulmonary Nodules.
Rundo L; Ledda RE; di Noia C; Sala E; Mauri G; Milanese G; Sverzellati N; Apolone G; Gilardi MC; Messa MC; Castiglioni I; Pastorino U
Diagnostics (Basel); 2021 Sep; 11(9):. PubMed ID: 34573951
[TBL] [Abstract][Full Text] [Related]
80. Role of biomarkers in lung nodule evaluation.
Sethi S; Cicenia J
Curr Opin Pulm Med; 2022 Jul; 28(4):275-281. PubMed ID: 35749790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
